Carmen Cueto-Rodriguez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Selective Brain-Penetrant TTBK1 Inhibitors Modulate TDP-43 Pathology and Rescue Cognitive Deficits in a Mouse Model of TDP-43 Proteinopathy.
Journal: Journal of medicinal chemistry
Published: June 14, 2026
Resveratrol modulates pancreatic proteotoxic stress and metabolic dysfunction in human IAPP transgenic mice.
Journal: Frontiers in endocrinology
Published: May 03, 2026
Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.
Journal: Neuropharmacology
Published: October 04, 2025
Preclinical evaluation of cannabidiolic acid as a neuroprotective agent in TDP-43 transgenic mice, an experimental model of amyotrophic lateral sclerosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 14, 2025
Development of Novel Neuroprotective Agents Targeting GPCR Using in Vitro Assays.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2025
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB2 receptor activation in experimental ALS in male mice.
Journal: Cell communication and signaling : CCS
Published: January 27, 2025
Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia.
Journal: Antioxidants (Basel, Switzerland)
Published: July 30, 2024
Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 31, 2023
Editorial: Cannabinoids as potential treatment for neurological diseases.
Journal: Frontiers in neuroscience
Published: November 25, 2022
Endocannabinoid-Binding Receptors as Drug Targets.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 24, 2022
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice.
Journal: Journal of neuroinflammation
Published: August 24, 2022
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
Journal: Molecules (Basel, Switzerland)
Published: November 13, 2021
Last Updated: 09/26/2026